ACS Omega · 2018 · 83 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryLead Compound DesignOncology PharmacologyTyrosine Kinase InhibitorsAnticancer ActivityAntiproliferative AgentsAntiproliferative Drug ActionEgfr InhibitionEpidermal Growth Factor Receptor InhibitionTriazole ChemistryTyrosine Kinase InhibitionTyrosine Kinase Receptors
decreases the expression of EGFR and p-EGFR. It also induces apoptosis through reactive oxygen species generation, followed by the change in mitochondrial membrane potential.
23
Haider Raza, Annie John, Abderrahim Nemmar · Cellular Physiology and Biochemistry · 2013 · 47.3K citations · Full text
FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets
Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · The Oncologist · 2003 · 577 citations · Full text